Profits Before Safety: Why Are Legal Exemption Lines Drawn For Big Pharma?
Op-Ed by Catherine J. Frompovich There seems to be an enigma, double standard or even a legal faux pas in tort law in the United States. Nowhere is that more readily evident than in the following example, in my opinion. Back on July 19, 2018,…